Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB04983> ?p ?o ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- drugbank:DB04983 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04983 label "Denufosol [drugbank:DB04983]" assertion.
- drugbank:DB04983 seeAlso DB04983 assertion.
- drugbank:DB04983 description "Denufosol (INN) is an inhaled drug for the treatment of cystic fibrosis, being developed by Inspire Pharmaceuticals and sponsored by the Cystic Fibrosis Foundation. It was tested in two Phase III clinical trials, TIGER-1 and TIGER-2. Initially, in the first Phase III trial, TIGER-1, the compound showed significant results as compared with placebo. In the second Phase III trial, TIGER-2, the compound did not meet the primary endpoint, a significant change in baseline FEV1 (forced expiratory volume in one second) at the week 48 endpoint as compared to placebo. As of 2011, no additional clinical studies are being conducted with the compound. The drug was also investigated for the treatment of retinal detachment and other retinal diseases, but trials were terminated in 2006. [Wikipedia]" assertion.
- drugbank:DB04983 identifier "drugbank:DB04983" assertion.
- drugbank:DB04983 title "Denufosol" assertion.
- drugbank:DB04983 drugbank_vocabulary:x-cas cas:318250-11-2 assertion.
- drugbank:DB04983 drugbank_vocabulary:drugbank-id "DB04983" assertion.
- drugbank:DB04983 bio2rdf_vocabulary:x-identifiers.org DB04983 assertion.
- drugbank:DB04983 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04983" assertion.
- drugbank:DB04983 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04983 bio2rdf_vocabulary:identifier "DB04983" assertion.
- drugbank:DB04983 drugbank_vocabulary:x-kegg kegg:D03685 assertion.